Differential immune pathways in classic and mixed variants of anaplastic thyroid cancer.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e18579
Abstract: e18579Background: Patients with anaplastic thyroid cancer (ATC) have poor outcomes due to treatment resistance with an estimated 5-year survival rate of 7%. Although “classic” ATC can arise de novo... read more here.
Keywords: anaplastic thyroid; immune pathways; pathways classic; thyroid cancer ... See more keywords